您当前的位置:
首页 >
文章列表页 >
Practical study on the application of “BRAND” pharmaceutical care model in advanced NSCLC patients with positive driver genes
更新时间:2026-03-10
    • Practical study on the application of “BRAND” pharmaceutical care model in advanced NSCLC patients with positive driver genes

    • “Experts have developed the "BRAND" pharmaceutical service model, targeting patients with driver gene positive advanced non-small cell lung cancer. Through clinical practice verification, it has significantly improved patients' medication compliance and quality of life, providing a new path for precision and personalized tumor pharmaceutical services.”
    • ZHONGGUO YAOFANG   Vol. 37, Issue 5, Pages: 655-659(2026)
    • DOI:10.6039/j.issn.1001-0408.2026.05.18    

      CLC: R95
    • Received:24 September 2025,

      Revised:2026-02-12,

      Accepted:12 February 2026,

      Published:15 March 2026

    移动端阅览

  • YU Jiankang,GONG Wei,SHI Jinfang,et al.Practical study on the application of “BRAND” pharmaceutical care model in advanced NSCLC patients with positive driver genes[J].ZHONGGUO YAOFANG,2026,37(05):655-659. DOI: 10.6039/j.issn.1001-0408.2026.05.18.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Exploration of the comprehensive management practice pathway for long-term prescription medications in psychiatry
Construction and effectiveness analysis of working model of cough and asthma pharmaceutical care clinic
Exploration of the role of PIVAS pharmacists in optimization of parenteral nutrition prescription systems and medication safety monitoring
Influence evaluation of pharmaceutical quality control on medication therapy management services by the ECHO model
Scoping review of pharmaceutical service provided by community pharmacists for patients with chronic diseases in China

Related Author

NIU Mengxi
LI Pengfei
WANG Xue
LIU Shanshan
CAO Yanxiang
ZHUANG Hongyan
WANG Hu
BAI Li

Related Institution

Advanced Innovation Center for Human Brain Protection, Capital Medical University
Beijing Key Laboratory of Critical Bridging Technologies for Chronic Disease Drug Development/Pharmacy Department, Beijing Anding Hospital, Capital Medical University
Dept. of Pharmacy, the First Affiliated Hospital of Anhui University of Chinese Medicine
Dept. of Nursing, the First Affiliated Hospital of Soochow University
Dept. of Pharmacy, the Second Affiliated Hospital of Hebei North University
0